Glenmede Trust’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,228,287
| Closed | -$122K | – | 3253 |
|
|
2019
Q3 | $122K | Sell |
1,228,287
-12,100
| -1% | -$1.15M | 0.56% | 39 |
|
|
2019
Q2 | $115K | Sell |
1,240,387
-12,912
| -1% | -$1.23M | 0.5% | 44 |
|
|
2019
Q1 | $118K | Sell |
1,253,299
-89,051
| -7% | -$7.79M | 0.53% | 42 |
|
|
2018
Q4 | $86K | Buy |
1,342,350
+261,488
| +24% | +$19.3M | 0.42% | 56 |
|
|
2018
Q3 | $96.7M | Buy |
1,080,862
+702,573
| +186% | +$62.1M | 0.39% | 57 |
|
|
2018
Q2 | $30M | Sell |
378,289
-401,758
| -52% | -$33.4M | 0.13% | 233 |
|
|
2018
Q1 | $81.4M | Hold |
780,047
| – | – | 0.34% | 71 |
|
|
2017
Q4 | $81.4M | Sell |
780,047
-23,018
| -3% | -$2.6M | 0.34% | 71 |
|
|
2017
Q3 | $117M | Sell |
803,065
-10,368
| -1% | -$1.41M | 0.51% | 43 |
|
|
2017
Q2 | $101M | Hold |
813,433
| – | – | 0.48% | 40 |
|
|
2017
Q1 | $101M | Buy |
813,433
+365,300
| +82% | +$43.7M | 0.48% | 40 |
|
|
2016
Q4 | $51.9M | Buy |
448,133
+2,690
| +0.6% | +$300K | 0.28% | 93 |
|
|
2016
Q3 | $46.6M | Sell |
445,443
-137,740
| -24% | -$14.9M | 0.26% | 97 |
|
|
2016
Q2 | $57.5M | Buy |
583,183
+47,397
| +9% | +$4.9M | 0.35% | 69 |
|
|
2016
Q1 | $53.6M | Sell |
535,786
-4,298
| -0.8% | -$443K | 0.35% | 68 |
|
|
2015
Q4 | $64.7M | Sell |
540,084
-26,898
| -5% | -$3.11M | 0.44% | 54 |
|
|
2015
Q3 | $61.3M | Buy |
566,982
+46,747
| +9% | +$5.8M | 0.45% | 48 |
|
|
2015
Q2 | $60.2M | Buy |
520,235
+142,534
| +38% | +$16.3M | 0.43% | 45 |
|
|
2015
Q1 | $43.5M | Buy |
377,701
+65,848
| +21% | +$7.87M | 0.32% | 76 |
|
|
2014
Q4 | $34.9M | Buy |
311,853
+10,734
| +4% | +$1.13M | 0.27% | 92 |
|
|
2014
Q3 | $28.5M | Buy |
301,119
+16,270
| +6% | +$1.47M | 0.25% | 93 |
|
|
2014
Q2 | $24.5M | Sell |
284,849
-33,401
| -10% | -$2.54M | 0.22% | 106 |
|
|
2014
Q1 | $22.2M | Buy |
318,250
+60,178
| +23% | +$4.77M | 0.21% | 113 |
|
|
2013
Q4 | $21.8M | Buy |
258,072
+2,398
| +0.9% | +$190K | 0.22% | 98 |
|
|
2013
Q3 | $19.7M | Buy |
255,674
+11,106
| +5% | +$778K | 0.23% | 98 |
|
|
2013
Q2 | $14.3M | Buy |
+244,568
| New | +$14.7M | 0.18% | 118 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Glenmede Trust's CELG Position: Q4 2019 in Review
Glenmede Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,228,287 shares — an estimated $122K sold.
Glenmede Trust first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $117M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Glenmede Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Glenmede Trust sold 1,228,287 Celgene Corp shares in Q4 2019, an estimated $122K.
- Glenmede Trust first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Glenmede Trust's Celgene Corp position peaked at $117M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.